Gefitinib is a drug used in the treatment of certain types of cancer. Gefitinib is an EGFR inhibitor, like erlotinib, selectively targeting proteins in malignant cells. It is marketed by astrazeneca.
Product Disclaimer : The Seller / Buyer offers no guarantee that any claims of Patents, Drugs, Explosives, Narcotics, or any other outlawed by Government Authorities that cover the use or Sale / Purchase of the products listed above won't be violated, and it's the Buyer's / Seller's risk and liability.